Has Pradip Baiju, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,161 in general payments to Pradip Baiju, MD across 31 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pradip Baiju, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pradip Baiju, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pradip Baiju, MD

Interventional Cardiology · Orlando, FLNPI 1831192186

Payments from drug & device makers

$1,161in general payments, 2019–2025

Across 31 payments — averaging $37.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$964
Pfizer$68
E.r. Squibb & Sons, L.L.C.$41
Cook Medical LLC$32
Johnson & Johnson$31
Bard Peripheral Vascular, Inc.$14
plus $11 from 1 others

What the payments were for

Food & beverage$1,09394%
Education$686%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	18	$964
Pfizer	4	$68
E.r. Squibb & Sons, L.L.C.	3	$41
Cook Medical LLC	2	$32
Johnson & Johnson	2	$31
Bard Peripheral Vascular, Inc.	1	$14
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

HawkOne$259
SilverHawk$102

How this compares

$1,161 in reported general payments places this provider in the 10th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$883,375

Medicare patients

221

Services billed

1,359

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XareltoRivaroxaban	171	$189,066
EliquisApixaban	101	$127,553
EntrestoSacubitril/Valsartan	13	$19,112
BrilintaTicagrelor	14	$8,896
ClopidogrelClopidogrel Bisulfate	487	$5,437
Cilostazol	53	$834
Atorvastatin Calcium	82	$792
Metoprolol Succinate	57	$682
Rosuvastatin Calcium	40	$680
Amlodipine-ValsartanAmlodipine Besylate/Valsartan	12	$487
Cefdinir	17	$437
Losartan Potassium	45	$436
Isosorbide Mononitrate ErIsosorbide Mononitrate	50	$378
Spironolactone	17	$315
Carvedilol	31	$312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonXarelto	$31	$189,066171 claims
PfizerEliquis	$68	$127,553101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 623 interventional cardiology providers in Florida.

Other interventional cardiology in Orlando

Vijaykumar KasiOrlando$1.1M
Zahid AminOrlando$670K
Farhan KhawajaOrlando$636K
Dominick AngiolilloJacksonville$4M
Douglas SpriggsClearwater$3.2M
Rakesh PrashadOcala$3.1M
Aldo Martinez FleitesMiami Lakes$2.2M
Rohit AminPensacola$2M
Roberto CubedduNaples$2M
Arthur LeeGainesville$2M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →